Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if it is safe and effective to give Lamisil to HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Fluconazole; Terbinafine

Criteria

Inclusion Criteria

You may be eligible for this study if you:

• Are at least 18 years old.

• Have thrush that has not responded to at least 10 days of fluconazole treatment.

• Are HIV-positive.

• Are expected to live at least 4 weeks.

• Are able to take oral medication.

Exclusion Criteria

You will not be eligible for this study if you:

• Have liver or kidney disease.

• Have received certain medications.

• Have a history of serious diarrhea or digestive problems.

• Are pregnant or breast-feeding.